<DOC>
	<DOCNO>NCT00836823</DOCNO>
	<brief_summary>Lower urinary tract symptom ( LUTS ) secondary benign prostatic hyperplasia ( BPH ) consist constellation symptom ( include voiding , storage , post-micturition ) . The impact LUTS patient ' health-related quality life substantial multifaceted . Thus , therapy aim treat BPH concern primarily improve patient ' symptom , thereby improve quality life . When multiple symptom present , level bother associate individual symptom varies patient prioritize treatment goal symptom relief . A measure address patient ' bothersome symptom ( MBS ) evaluation symptom-specific goal achievement may lead improved outcome patient satisfaction treatment . The objective study ( 1 ) ass patient-reported MBS symptom-specific goal achievement ( PGA ) medical treatment BPH patient , ( 2 ) identify factor influence relation PGA .</brief_summary>
	<brief_title>Evaluation Symptom-specific Goal Achievement</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>male ≥50 year LUTS secondary BPH Moderate severe LUTS : IPSS ≥ 8 An enlarged prostate : TRUS ≥25 mL Decreased peak flow rate : Qmax ≤15mL/s ( volume void ≥ 120 mL ) Having sign informed consent participate study . Post void residual urine ≥ 200mL Patients perform catheterization Urinary tract infection patient Patients take 5 alpha reductase inhibitor Known hypersensitivity alfuzosin History postural hypotension syncope Hypertension patient treat alpha1blockers Patients newly take anticholinergic medication within 1 month Hepatic insufficiency ( AST/ALT ≥ 2 time normal range ) Renal insufficiency ( sCr ≥ 2mg/dL ) Unstable angina pectoris Uninvestigated hematuria Serum PSA ≥ 4 ng/mL ( biopsy proven cancer patient include ) Interstitial cystitis patient Severe concomitant condition threaten life . Patient unable make void diary Bladder prostate cancer patient Patients receive prostate bladder surgery</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Patient-reported bothersome symptom</keyword>
	<keyword>Patient-reported symptom-specific goal achievement</keyword>
	<keyword>Medical treatment</keyword>
</DOC>